Press release
Investigation announced for Investors in shares of Kenvue Inc. (NYSE: KVUE) over possible Violations of Securities Laws
An investigation for investors in Kenvue Inc. (NYSE: KVUE) shares over potential securities laws violations by Kenvue Inc. was ann
Investors who purchased shares of Kenvue Inc. (NYSE: KVUE), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether certain statements by Kenvue Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Skillman, NJ based Kenvue Inc. operates as a consumer health company worldwide. On May 08, 2023, Kenvue Inc. (NYSE: KVUE) announced the closing of its initial public offering ("IPO") of 198,734,444 shares of its common stock at a price to the public of $22.00 per share, including the underwriters' full exercise of their option to purchase 25,921,884 shares to cover over-allotments. Shares of Kenvue's common stock began trading on the New York Stock Exchange under the symbol "KVUE" on May 4, 2023.
Shares of Kenvue Inc. (NYSE: KVUE) rose in the open market to $27.80 per share on May 15, 2023. Since then NYSE: KVUE shares declined to $20.47 per share on September 25, 2023.
Those who purchased shares of Kenvue Inc. (NYSE: KVUE) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Kenvue Inc. (NYSE: KVUE) over possible Violations of Securities Laws here
News-ID: 3226003 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Kenvue
Oral Rinse Market Outlook (2025-2032): Growth Drivers, Innovation Trends & Emerg …
Oral Rinse Market is estimated to be valued at USD 7.25 Bn in 2025 and is expected to reach USD 12.03 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2032.
The Oral Rinse Market : A thorough analysis of statistics about the current as well as emerging trends offers clarity regarding the Oral Rinse Market dynamics. The report includes Porter's Five Forces to…
Pharyngitis Treatment Market: Comprehensive Analysis and Key Players | Kenvue In …
The Pharyngitis Treatment Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/pharyngitis-treatment-market
What is the projected…
Pharyngitis Treatment Market Booming Worldwide With Leading - Pfizer Inc., Novar …
DataM Intelligence has published a new research report on "Pharyngitis Treatment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF -…
Investigation announced for Long-Term Investors who lost money with shares of Ke …
An investigation was announced for current long-term investors in shares of Kenvue Inc. (NYSE: KVUE) concerning potential breaches of fiduciary duties by certain directors of Kenvue Inc.
Investors who are current long term investors in Kenvue Inc. (NYSE: KVUE) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NYSE: KVUE stocks…
Skin Cleansing Disinfectant Market In-Depth Analysis, Growth Strategies and Comp …
LOS ANGELES, United States: The report named, "Global Skin Cleansing Disinfectant Market Research Report 2024" has been added to the archive of market research studies by QY Research. The industry experts and researchers have offered reliable and precise analysis of the global Skin Cleansing Disinfectant market in view of numerous aspects such as growth factors, challenges, limitations, developments, trends, and growth opportunities. This report will surely act as a handy…
Deadline on December 8th coming up in Lawsuit for Investors in Kenvue Inc. (NYSE …
A deadline is coming up on December 8, 2023 in the lawsuit filed for certain investors of Kenvue Inc. (NYSE: KVUE).
Investors who purchased shares of Kenvue Inc. (NYSE: KVUE) have certain options and there are strict and short deadlines running. Deadline: December 8, 2023. NYSE: KVUE stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of purchasers of Kenvue Inc. (NYSE:…
